Experimental diabetes upregulates the expression of uretereral endothelin receptors

Peptides

Volumn 18, Issue 7, 1997, Pages 1091-1093

  Nakamura, Isao ^a   Saito, Motoaki ^a   Fukumoto, Yuji ^a   Yoshida, Masaki ^a   Nishi, Kazuhiko ^a   Weiss, Robert ^a   Latifpour, Jamshid ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Endothelin receptor; Rat; Ureter

Indexed keywords

BQ 610; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE];

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CHO CELL; CONTROLLED STUDY; DIURESIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR UPREGULATION; STREPTOZOCIN DIABETES; URETER;

ANIMALS; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIN-1; ENDOTHELIN-3; ENDOTHELINS; HUMANS; MALE; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; RATS; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; UP-REGULATION; URETER;

ANIMALIA;

EID: 0030663349     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00026-0     Document Type: Article

References (11)

1. Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 348:1990;730-732.
2. Eguchi S., Kozuka M., Hirose S., Ito T., Hagiwara H. Unique contractile action of endothelins on porcine isolated ureter and characterization of the endothelin-binding sites. Biomed. Res. 12:1991;35-39.
3. Fukumoto Y., Yoshida M., Weiss R. M., Latifpour J. Reversibility of diabetes- and diuresis-induced alterations in rat bladder dome muscarinic receptors. Diabetes. 43:1994;819-826.
4. Garcia-Pascual A., Larsson B., Andersson K.-E. Contractile effects of endothelin-1 and localization of endothelin binding sites in rabbit lower urinary tract smooth muscle. Acta Physiol. Scand. 140:1990;545-555.
5. A receptors. Schneider C. H., Eberle A. N. Peptide. 1993;685-686 ESCOM, Leiden, The Netherlands.
6. Latifpour J., Fukumoto Y., Weiss R. M. Regional differences in the density and subtype specificity of endothelin receptors in rabbit urinary tract. Naunyn-Schmiedeberg's Arch. Pharmacol. 352:1995;459-468.
7. Maggi C. A., Giuliani S., Patacchini R., Rovero P., Giachetti A., Meli A. The activity of peptides of the endothelin family in various mammalian smooth muscle preparations. Eur. J. Pharmacol. 174:1989;23-31.
8. Masaki T., Yanagisawa M., Goto K. Physiology and pharmacology of endothelins. Med. Res. Rev. 12:1992;391-421.
9. Rubanyi G. M., Polokoff M. A. Endothelins Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Rev. 46:1994;325-415.
10. B receptor. Biochem. Biophys. Res. Commun. 184:1992;953-959.
11. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.